How Many Eggs Are Usually Enough for IVF?

Key Takeaways

IVF success is not about chasing the biggest egg count. In older fresh-cycle data, the live birth rate rose with the number of eggs up to about 15 and then levelled off; when later frozen transfers are counted, the cumulative chance of live birth can keep rising beyond 15, with diminishing returns. Neither is a universal target, and safety matters more as numbers climb. Age, maturity, fertilisation, embryo development and the safety of stimulation all matter; ovarian reserve tests predict egg yield more reliably than live birth.

Key evidence: Association between oocyte number and live birth in 400,135 IVF cycles · ASRM committee opinion on ovarian-reserve testing · ASRM guideline on prevention of moderate and severe OHSS

How Many Eggs Are Usually Enough for IVF?

Patients often focus on egg count because it is one of the first visible numbers in an IVF cycle. That makes sense, but the number matters mainly because it changes the chance of reaching an embryo that can continue developing. In a large UK registry analysis, live-birth rates rose with egg number up to about 15, then plateaued before declining at higher counts; this was an observational association, not a prescription for every patient. The study was based on fresh IVF cycles and older treatment data. Age and embryo development still matter greatly, as does the safety of stimulation. See also our IVF success rates by age.

Why Egg Count Matters at All

IVF works like a funnel.

• only some retrieved eggs are mature,
• only some mature eggs fertilise normally,
• and only some embryos continue developing to a stage suitable for transfer or freezing.

That is why a higher egg count can improve the odds of reaching a usable embryo cohort. It does not guarantee success by itself.

Egg Number and Egg Competence Are Different Things

More eggs generally mean more fertilised eggs and more blastocysts, and therefore more opportunities to obtain a usable embryo (Fanton et al., 2023). But egg count does not tell us whether an individual egg is developmentally or chromosomally competent, and age remains one of the strongest influences on that. Even a large retrieval does not guarantee a transferable embryo if fertilisation fails or embryos stop developing early. A smaller cohort can still produce a good outcome; the number retrieved is an opportunity measure, not a direct test of chromosomal competence.

Morphology can tell us something, but it does not fully reveal chromosomal competence. This is one reason age remains important when clinicians discuss prognosis. Ovarian-reserve markers such as AMH and AFC are useful for anticipating egg yield, but ASRM notes that they are poor independent predictors of reproductive potential and live birth. ASRM’s committee opinion

The Role of Age

Age is one of the most important influences on egg quality and IVF prognosis.

• Under 35: chromosomal abnormalities are less common overall than at later reproductive ages.
• After 40: chromosomal abnormalities become more common, so the same number of retrieved eggs may yield fewer developmentally competent embryos.

This helps explain why pregnancy rates decline and miscarriage risk rises with age, even in cycles where several eggs are retrieved. In 15,169 embryo biopsies, aneuploidy was lowest between ages 26 and 30 and rose steadily afterwards (Franasiak et al., 2014). In the UK registry analysis, the predicted live birth rate with 15 eggs (cycles from 2006 to 2007) was 40%, 36%, 27% and 16% at ages 18–34, 35–37, 38–39 and 40 or over (Sunkara et al., 2011). In a Norwegian register of 421,201 pregnancies, the risk of miscarriage was lowest at ages 25–29 (10%) and rose rapidly after 30 (Magnus et al., 2019).

Other health factors can also affect treatment planning, but their contribution is not captured by a simple egg-count formula. Smoking, metabolic health and medication history are best discussed individually rather than turned into a universal egg-quality checklist.

Is There an Ideal Number of Eggs for IVF?

There is no single ideal number. In a large analysis of UK IVF cycles from 1991 to 2008, the live birth rate rose with the number of eggs up to about 15 retrieved oocytes, levelled off between 15 and 20 and declined beyond 20 (Sunkara et al., 2011). A smaller single-centre study of 1,567 young women with normal ovarian reserve (first long-protocol cycle) found the best fresh-cycle results with 10 to 12 oocytes, and the share at high risk of ovarian hyperstimulation syndrome (OHSS) rose as the count increased (Chen et al., 2015). These are fresh-cycle results. When all embryos from one retrieval are counted, including later frozen transfers, the picture changes. In 14,469 women treated from 2009 to 2014, the cumulative live birth rate kept rising with the number of eggs and reached 70% with 25 or more, without a clear plateau (Polyzos et al., 2018). In 402,411 US cycles from 2014 to 2019, it rose quickly up to about 16–20 eggs and then continued to rise with diminishing returns (Fanton et al., 2023). In a pooled analysis of four trials with 1,746 patients, it levelled off at 21–25 eggs, although few patients had 20 or more (Lobo et al., 2025). None of these figures is a rule, a treatment target or a minimum. The same number can mean something very different at different ages and with different laboratory outcomes.

A very high response can create a different problem. A high number of mature follicles or retrieved oocytes is associated with greater OHSS risk, so the stimulation plan and trigger are adjusted around the patient’s response rather than around a fixed egg target. ASRM OHSS guidance In older registry data, OHSS risk began to rise noticeably beyond about 15 retrieved eggs (Steward et al., 2014); current ESHRE terminology uses around 18 or more eggs to define a high response (ESHRE guideline, 2025). Neither number is a cliff-edge safety threshold.

The IVF Laboratory Pathway

This is a framework, not a prediction table. The proportions vary with age, sperm factors, insemination method, laboratory practice and the definition of each outcome. Each step reduces the number, but the purpose is to identify embryos with developmental potential rather than to meet a quota.

What If You Have Fewer Eggs?

Fewer eggs do not automatically mean failure. A cycle may still produce a transferable embryo, although the probability of reaching one generally falls as fewer oocytes are available. Ovarian reserve testing can help anticipate response, but it cannot determine the result of an individual cycle on its own.

When ovarian response is limited, clinicians may discuss:

• embryo or oocyte banking across more than one cycle,
• protocol adjustments,
• or, when the aim is to accumulate eggs or embryos and a fresh transfer is not planned, double stimulation (DuoStim) (ESHRE guideline, 2025).

The question is not only how many eggs were retrieved, but what those eggs may still realistically produce.

What If You Have Many Eggs?

When the response is very high, the discussion often shifts toward safety.

For patients at increased risk of OHSS, a freeze-all strategy may be considered as part of a broader prevention plan. It can reduce the risk of late-onset OHSS, the form linked to an early pregnancy, when used in the appropriate clinical setting (ESHRE guideline, 2025), but it is not automatically safer or more effective for every patient. ASRM OHSS guidance

What Can Be Discussed Over Several Months?

Egg development and follicle recruitment take place over time, but there is no reliable “90-day reset” that guarantees better IVF outcomes. Sleep, nutrition, exercise, smoking and metabolic health can still matter to general preconception care and treatment planning; they should not be presented as a promise to increase egg yield.

Supplements Patients Ask About

Patients sometimes ask about supplements such as CoQ10 or DHEA. The current ESHRE guideline recommends against DHEA before or during ovarian stimulation, both for low and for normal responders (ESHRE guideline, 2025). CoQ10 is not covered by that guideline and is not a universal IVF requirement. Folic acid belongs to routine preconception planning rather than to a promise of improved egg quality. Any supplement should be reviewed with the treating clinician for indication, interactions and safety.

Related Reading

• How Many Eggs Do You Really Need to Freeze?
• Ovarian PRP: What It Is and Why It Is Still Experimental
• Exosomes for Ovarian Rejuvenation: Why the Idea Is Still Experimental

Frequently Asked Questions for Dr. Aksoy

How many embryos can I expect from the eggs retrieved, and what changes it most?

Not every retrieved egg becomes an embryo. Some eggs are immature, some mature eggs do not fertilise normally, and some fertilised eggs stop developing before the blastocyst stage. Two or three blastocysts from 10 eggs can be compatible with an ordinary IVF cycle, but that is not the expected result for every patient; the variation between patients is very large. The factors that change it most are the woman’s age, the maturity and quality of the eggs, the sperm factor and the performance of the laboratory. If PGT-A (genetic testing of embryos for an abnormal chromosome number) is planned, age matters even more, because the chance that a blastocyst is euploid falls markedly with age.

Laboratory quality indicators such as the ESHRE Vienna consensus describe the maturity, fertilisation and blastocyst-development rates a laboratory should reach, but these are benchmarks for laboratories, not a prediction for one patient (Vienna consensus, 2017). In 15,169 trophectoderm biopsies, among patients who had blastocysts to biopsy, the share with no euploid embryo was 2% to 6% between ages 26 and 37, 33% at age 42 and 53% at age 44 (Franasiak et al., 2014).

At what number of eggs do you call a retrieval low, expected or high?

I do not classify this by age alone. Age mostly reflects egg quality and the chance of a chromosomally normal embryo; AMH, the antral follicle count and the response to a previous stimulation tell me better how many eggs to expect. In the current ESHRE definition, three or fewer eggs count as a low response and around 18 or more as a high response; the wide range in between is judged patient by patient (ESHRE guideline, 2025). For example, 5 eggs can be an expected and good response in a 41-year-old with low reserve, while the same number can be low in a young woman with high reserve.

For orientation, in a large UK registry analysis of IVF cycles from 1991 to 2008, the median was 9 eggs per cycle (interquartile range 6 to 13) (Sunkara et al., 2011).

How many mature (MII) eggs are enough for IVF?

There is no single “enough” number of mature eggs in IVF. The aim is not to reach a particular egg count but to build a cohort that gives at least one transferable embryo and, if possible, extra embryos for later transfers. I do not use a fixed threshold such as “8 MII is enough”, because the same 8 mature eggs mean something different in a 28-year-old and in a 41-year-old; age, the sperm factor, the fertilisation rate and blastocyst development change the result markedly. So I treat the MII count as the start of the embryo funnel: some of the mature eggs fertilise, and only some of the fertilised ones reach a good-quality blastocyst. At older ages, more eggs may be needed to obtain the same number of blastocysts or euploid embryos.

Fresh-cycle live birth tends to level off at around 15 retrieved eggs, while the cumulative chance of live birth, counting later frozen transfers from the same retrieval, keeps rising with the egg count, although with diminishing returns (Polyzos et al., 2018; Fanton et al., 2023). There are much stronger population data for the total number of retrieved eggs than for a universal MII target, which is another reason I do not define a fixed “enough” MII number.

Is 15 eggs the ideal number for IVF?

For most patients, 15 eggs is a very good response, but it is not right to say that the ideal number is exactly 15. In a systematic review, fresh-cycle live birth rates were highest at roughly 12 to 18 retrieved eggs, with 15 the most common suggestion; when frozen embryos are also counted, the cumulative chance of live birth keeps rising with the egg count for a while longer (Law et al., 2021).

The number alone still does not decide the outcome; age, the proportion of mature (MII) eggs, fertilisation and blastocyst development matter more. ESHRE also regards around 18 or more eggs as a high ovarian response, and beyond that point the risk of OHSS becomes more important (ESHRE guideline, 2025). In short, 15 eggs is not a magic number to aim for, but in IVF it is usually a strong and well-balanced cohort.

Final Thoughts

Egg count matters because it affects probability, but it is not the whole story. In older fresh-cycle data, the live birth rate levelled off at around 15 eggs, while the cumulative chance including frozen transfers can keep rising beyond that with diminishing returns; neither is a guarantee, minimum or universal target. The more useful question is how many eggs are mature, how they fertilise, how embryos develop and what the safest plan is for that individual cycle.

Continue Reading

• Egg Retrieval Procedure
• Embryo Transfer Explained

Sources

• Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
• Chen YH, Xu XH, Wang Q, Zhang SD, Jiang LL, Zhang CL, Ge ZJ. Optimum oocyte retrieved and transfer strategy in young women with normal ovarian reserve undergoing a long treatment protocol: a retrospective cohort study. J Assist Reprod Genet 2015;32(10):1459–1467.
• American Society for Reproductive Medicine. Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 2024;121(2):230–245.
• American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion.
• Ata B, Bosch E, Broer S, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025. Hum Reprod 2026;41(4):498–514.
• ESHRE. Ovarian stimulation guideline: information for patients (2025) — source of the low-response definition (three or fewer follicles or eggs); for a high response the leaflet gives more than 18 follicles or eggs, which the text rounds to around 18 or more.
• ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Reprod Biomed Online 2017;35(5):494–510.
• Franasiak JM et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril 2014;101(3):656–663.e1.
• Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ 2019;364:l869.
• Steward RG et al. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril 2014;101(4):967–973.
• Polyzos NP, Drakopoulos P, Parra J, et al. Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women. Fertil Steril 2018;110(4):661–670.e1.
• Fanton M, Cho JH, Baker VL, Loewke K. A higher number of oocytes retrieved is associated with an increase in fertilized oocytes, blastocysts, and cumulative live birth rates. Fertil Steril 2023;119(5):762–769.
• Lobo R, Santos-Ribeiro S, Falahati A, et al. One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials. Hum Reprod 2025;40(8):1526–1534.
• Law YJ, Zhang N, Kolibianakis EM, et al. Is there an optimal number of oocytes retrieved at which live birth rates or cumulative live birth rates per aspiration are maximized after ART? A systematic review. Reprod Biomed Online 2021;42(1):83–104.

Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed · ORCID · LinkedIn

Read full profile → Instagram YouTube

The content has been created by Dr. Senai Aksoy and medically approved.